Pembrolizumab + Lenvatinib

DRUG2 trials

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Saint Petersburg State University, Russia

Conditions

Anaplastic Thyroid CancerClassic Kaposi SarcomaKaposi SarcomaRefractory Kaposi Sarcoma

Phase 2

Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma

WithdrawnNCT05846724

Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoClassic Kaposi Sarcoma, Kaposi Sarcoma, Refractory Kaposi Sarcoma

Start: 2024-02-01End: 2030-02-01Updated: 2026-01-22

Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer

RecruitingNCT06374602

Saint Petersburg State University, RussiaAnaplastic Thyroid Cancer

Start: 2024-03-25End: 2026-06-25Target: 20Updated: 2025-09-05